NovaBay Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

15,439

0.09%

07/31/2018

iShares Micro Cap ETF

13,854

0.08%

09/06/2018

Vanguard Total Stock Market Index Fund

11,471

0.07%

07/31/2018

Fidelity Spartan Extended Market Index Fund

5,692

0.03%

07/31/2018

Bridgeway Ultra Small Company Market Fund

2,000

0.01%

12/31/2017

1,389

0.01%

09/05/2018

AXA/Lord Abbett Micro Cap Portfolio

679

03/31/2018

iShares Core S&P Total US Stock Market ETF

657

09/06/2018

View Profile

Address	2000 Powell Street Emeryville California 94608 United States
Employees	-
Website	http://novabay.com
Updated	07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.